-
1.
公开(公告)号:US20250101627A1
公开(公告)日:2025-03-27
申请号:US18832129
申请日:2022-11-11
Inventor: Xue QU , Miao LEI , Changsheng LIU
Abstract: A preparation method of a collagen material stripped from an electrode and a use of the collagen material are provided. The preparation method of a collagen material stripped from an electrode includes the following step: subjecting a collagen solution including hydrogen peroxide and/or acetic acid to electro-deposition (EDP) to obtain the collagen material on the electrode. The preparation method can lead to a collagen material directly on a surface of an electrode.
-
2.
公开(公告)号:US20230414262A1
公开(公告)日:2023-12-28
申请号:US17905561
申请日:2021-03-02
Inventor: Changsheng LIU , Yulin LI , Wei LUO , Can CHEN
IPC: A61B17/86 , A61L27/12 , A61L27/18 , A61L27/54 , A61L27/58 , A61L31/12 , B29B9/12 , B29C71/02 , B29C45/77 , B29C45/78 , B29C48/92
CPC classification number: A61B17/86 , A61L27/12 , A61L27/18 , A61L27/54 , A61L27/58 , A61L31/127 , B29B9/12 , B29C71/02 , B29C45/77 , B29C45/78 , B29C48/92 , B29K2067/046
Abstract: The present invention relates to a high-strength absorbable composite active internal fixation device and a preparation method therefor. Specifically, the present invention discloses the internal fixation device and its preparation method, which possess excellent biological activity and mechanical properties.
-
公开(公告)号:US20220106568A1
公开(公告)日:2022-04-07
申请号:US17427737
申请日:2020-01-21
Inventor: Changsheng LIU , Kai DAI , Jing WANG , Qinghao ZHANG , Shunshu DENG , Guilong LI
IPC: C12N5/0775 , A61P37/06 , A61K35/12
Abstract: Disclosed are a stem cell generator, a construction method therefor and the use thereof. The stem cell generator is formed by implanting a biomaterial loaded with active substances and/or cells, or a biomaterial with an osteogenic induction capability into animal or human bodies and producing organoids upon development.
-
公开(公告)号:US20150337025A1
公开(公告)日:2015-11-26
申请号:US14653276
申请日:2013-12-05
Inventor: Changsheng LIU , Wanli XING , Jing WANG , Jiangchao QIAN , Jing LIANG
IPC: C07K14/51 , A61K9/00 , A61K38/18 , A61K31/664
CPC classification number: C07K14/51 , A61K9/0019 , A61K31/664 , A61K38/1875 , A61K38/193 , C07K2319/33
Abstract: Disclosed is the use of a fusion protein in drugs for stimulating differentiation of bone marrow mesenchymal stem cells to hematopoietic stem/progenitor cells, or drugs for proliferation of granulocyte hematopoietic progenitor cells. The fusion protein has a sequence as shown in SEQ ID NO: 2 or SEQ ID NO: 4. The drugs can be used for the prevention and/or treatment of (i) hematopoietic dysfunction caused by chemotherapy, (ii) hematopoietic dysfunction caused by radiotherapy, or (iii) leukopenia.
Abstract translation: 公开了在药物中使用融合蛋白来刺激骨髓间充质干细胞分化成造血干细胞/祖细胞或用于粒细胞造血祖细胞增殖的药物。 融合蛋白具有如SEQ ID NO:2或SEQ ID NO:4所示的序列。该药物可用于预防和/或治疗(i)由化疗引起的造血功能障碍,(ii)造血功能障碍引起的 放射治疗,或(iii)白细胞减少。
-
-
-